VEGFA and glioblastoma: The pathology of glioblastoma is characterized by the overexpression of vascular endothelial growth factor-A (VEGF-A) (Chinot et al., 2011; Hicklin and Ellis, 2005), prompting the development of therapies targeting the angiogenic pathway (Batchelor et al., 2014).